Evaluation of serum zinc level in patients with newly diagnosed and resistant alopecia areata

• Published in: International journal of dermatology Vol. 55; no. 1; pp. 24 - 29
• Main Authors: Abdel Fattah, Nermeen S. A., Atef, Mona M., Al-Qaradaghi, Suzan M. Q.
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01-01-2016
• Subjects: Adolescent; Adult; Age Factors; Alopecia Areata - blood; Alopecia Areata - drug therapy; Alopecia Areata - physiopathology; Analysis of Variance; Case-Control Studies; Confidence Intervals; Drug Resistance; Female; Humans; Male; Prognosis; Reference Values; Severity of Illness Index; Sex Factors; Statistics, Nonparametric; Trace Elements - blood; Young Adult; Zinc - blood
• ISSN: 0011-9059; 1365-4632
• DOI: 10.1111/ijd.12769

Background
Alopecia areata (AA) is a non‐scarring, autoimmune, inflammatory hair loss disease. Zinc is a trace element involved in important functional activities of hair follicles.
Purpose
To evaluate serum zinc levels in patients with newly diagnosed and resistant lesions of AA in comparison to age‐ and sex‐matched healthy controls.
Methods
The present study included 100 subjects: 50 patients with AA divided into two equally distributed subgroups (25 patients with recent onset AA [subgroup 1] and 25 patients with resistant AA [subgroup 2]) and 50 age‐ and sex‐matched healthy controls. Serum zinc levels were assessed in all subjects. Comparison of mean serum zinc levels was done between all patients and controls, between patients' subgroups as well as between patient's subgroup and controls. Correlations between serum zinc level and extent of AA and its duration were also done in all patients and each patient's subgroup.
Results
A significantly lower serum zinc level was found in patients with AA compared with controls and was significantly lower in patients with resistant AA compared to patients with newly diagnosed AA. Significant inverse correlations existed between serum zinc level, severity of AA, and disease duration in all patients as well as in patients with resistant AA.
Conclusion
Lower serum zinc level existed in patients with AA and correlated inversely with disease duration, severity of AA, and its resistance to therapies. Therefore, assessment of serum zinc level in patients with AA appears useful as a marker of severity, disease duration, and resistance to therapies. Accordingly, zinc supplements may provide a therapeutic benefit.